By The Colourboard Desk
The Coronavirus vaccine developed by Oxford university and Astrazeneca was safe and produced an immune response in early stage clinical trails on humans, data showed on Monday.
After month's of research, Sarah Gilbert, a vaccine developer from Oxfords Jenner institute said they were more than happy with the first results after a single shot of vaccine.
"The end of the year target for getting vaccine rollout, it's a possibility but there's absolutely no certainty about that because we need three things to happen" said Gilbert on BBC radio.
She continued "it needs to be shown to work in late stage trails, there need to be a large quantities manufactured and regulators have to agree quickly to license it for emergency use."
The vaccine did not show any serious side effects, but many people on trail had either fever or headache which can be managed by paracetamol said researchers.
It will be a early to say that coronavirus now has a cure because phase trials are still underway. Currently, phase III trails begun in Brazil and south Africa.